Brief: Chimeric Therapeutics Secures Up To A$12.6 Mln Through SPP
23/06/2023 09:58
June 23 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* SECURES UP TO A$12.6M THROUGH SPP
* SECURES INVESTMENT OF UP TO A$10M TO SUPPORT CLINICAL
PROGRAMME
* UNDER SPP, NEW SHARES WERE OFFERED AT LOWER OF A$0.04 EACH
SHARE
Source text for Eikon: ID:nASX3BPMhC
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial